Doctors stunned after promising heart drug fails major study

4 hours ago 1

Novartis’ experimental drug pelacarsen dramatically lowered lipoprotein(a), a genetic cardiovascular risk factor, but failed to significantly reduce heart attacks, strokes or cardiovascular deaths in a major late-stage clinical trial. (AP Photo/Mark Lennihan)

For years, heart doctors believed they might finally have a new way to prevent heart attacks and strokes in millions of people.

Read Entire Article